At OBBI, quality is embedded throughout the entire bioproduction pipeline—from the earliest stages of cell growth to the final release of organoids or extracellular vesicles (EVs). Our dedicated Quality control Bioprod facility provides expert support to monitor and validate key parameters across all phases of bioproduction. This ensures that every batch meets high standards of performance, reproducibility, and scalability, aligned with both scientific expectations and regulatory requirements.
We implement rigorous quality checks during cell expansion, culture conditions, and bioprocess setup to ensure robust and stable growth environments for organoid and EV production. Real-time monitoring and batch-to-batch consistency are central to this phase, with continuous validation of raw materials, media, and culture conditions.
Once the final products are obtained, we apply specific analytical methods to characterize their identity, purity, functionality, and stability. For organoids, this may include structural integrity and cellular composition; for EVs, surface markers, size distribution, and content profiling. These downstream analyses confirm that each product matches its intended use—whether for research, preclinical development, or translational applications.
OBBI applies quality control at three distinct levels, tailored to the complexity of each product and its intended use:
Standard tests for routine quality validation—such as morphology, viability, and contamination screening.
Customized assays adapted to the specific biological and functional characteristics of each organoid or extracellular vesicle type.
Basic and advanced Quality Controls for cells and 3D objects
OBBI implements a rigorous Quality Control Strategy framework to ensure the robustness, reproducibility, and compliance of organoid bioproductions.
Standard Quality Controls
Advanced characterization
Optimizing bioproduction with AI :
Regulatory compliance
Basic and advanced Quality Controls for extracellular vesicles
Advanced analytical solutions developed for novel applications, such as clinical like-grade standards.
This structured system ensures every project benefits from appropriate, scalable, and regulatory-aligned quality oversight—from early-stage research to pre industrial production.
